Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Telo Genomics Corp V.TELO

Alternate Symbol(s):  TDSGF

Healthcare Industrials Biotechnology Conglomerates
Telo Genomics Corp. is a biotech company pioneering the telomere platform in the industry with applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. The Company's lead application, TELO-MM is being developed to provide actionable information to medical professionals in the treatment of multiple myeloma, a form of... see more

Bullboard (TSXV:TELO)

View:
1 2 3 4 5 6 Next
Comment by bmreedon Nov 20, 2023 12:56pm

RE:Webinar $TELO CEO Kris Weinberg Nov 21st @ 1PM ET / 10AM PT

This webinar has been post-poned. When the recheduled date has been confirmed we will post it to this board. Thank you for your understanding.
107
Discussion
Post by bmreedon Nov 17, 2023 5:29pm

Webinar $TELO CEO Kris Weinberg Nov 21st @ 1PM ET / 10AM PT

Live Webinar - Telo Genomics Corp $TELO w/ CEO Kris Weinberg Tuesday, November 21st at 1PM ET / 10AM PT Q&A with Radius Research  Register Here - https://us02web.zoom.us/webinar ...more  
191
Discussion
Post by lance1997on Aug 06, 2023 7:03am

August

Phase 1 should be ongoing now. 
141
Post by westdakotadaveon May 17, 2023 10:46am

82% Accurate Blood Test

$TDSGF $TELO.V 82% Accurate Blood Test     SEE: European Hematology Association Abstract P975   https://library.ehaweb.org/eha/2023/eha2023-congress/386804/shaji.kumar ...more  
227
Post by westdakotadaveon May 17, 2023 10:44am

TeloGenomics Mayo Abstract

$TDSGF $TELO.V TeloGenomics Mayo Clinic results presented at ASCO. https://meetings.asco.org/abstracts-presentations/226578
131
Post by westdakotadaveon Apr 18, 2023 12:13pm

$TDSGF Mayo Clinic Results

$TELO.V $TDSGF The Mayo Clinic study "has exceeded its targeted endpoints". See 9/14/2022 Press Release.
233
Post by westdakotadaveon Apr 15, 2023 3:23pm

TeloGenomics @ ASCO with approved Abstract

It is at ASCO at Booth IH18 from June 2-6, 2023 not at ASH as posted befoere this.
199
Post by westdakotadaveon Apr 15, 2023 3:21pm

TeloGenomics @ASCO

ASCO Abstract approved for release and publication. See Telo Genomics at Booth 3243 at ASH 2022 Conference.
179
Post by westdakotadaveon Mar 21, 2023 11:10am

$TDSGF

$TDSGF Telo Genomics at Booth IH18 from June 2-6, 2023 at American Society of Clinical Oncology (ASCO).
173
Post by westdakotadaveon Mar 17, 2023 2:12pm

$TDSGF GAMEPLAN

$TDSGF GAMEPLAN per Feb 28, 2023 Filing (SEDAR MD&A)   March 2023 = Mayo SMM results have been submitted to the American Society of Clinical Oncology (ASCO) for presentation. June 2023  ...more  
213
Post by westdakotadaveon Nov 01, 2022 1:02pm

TELO Abstract

American Society of Hematology (ASH) Abstract Schedule Abstracts available online November 3, 2022, 9:00 a.m. Eastern time Late-breaking abstracts available online November 22, 2022. ASH ANNUAL ...more  
700
Post by toasted101on Jul 13, 2022 6:26pm

Telo Clinical Study of Drug Resistance for Multiple Myeloma

Telo Genomics Launches Clinical Study of Drug Resistance Test for Multiple Myeloma Toronto, Ontario--(Newsfile Corp. - July 13, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the  ...more  
347
Discussion
Post by bandi10on Jul 07, 2022 12:18pm

news

Telo Genomics Completes Processing and Analysis of Smoldering Multiple Myeloma Patient Samples Toronto, Ontario--(Newsfile Corp. - July 6, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF ...more  
238
Post by toasted101on May 31, 2022 10:04am

Telo Announces Validation of Its Proprietary Tools for SMM

Telo Genomics Announces Successful Validation of Its Proprietary Automation Tools for Smoldering Multiple Myeloma Toronto, Ontario--(Newsfile Corp. - May 31, 2022) - Telo Genomics Corp. (TSXV ...more  
242
Post by bandi10on Apr 11, 2022 7:25pm

huge volume

Something good must be up for this volume of today.
262
1 2 3 4 5 6 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities